Stakeholder Perspectives on Shifting Measles Vaccination (MCV1) to 6 Months

Stakeholder Perspectives on Shifting MCV1 to 6 Months synthesizes findings from a multi-country qualitative study in the Democratic Republic of the Congo, Nigeria, Pakistan, and Malawi, exploring the acceptability of moving the first dose of measles-containing vaccine (MCV1) from 9 months to 6 months of...